tetano
Editor, Senior Moderator
Intern Med
. 2023 Aug 9.
doi: 10.2169/internalmedicine.2293-23. Online ahead of print. Successful Management of Critical Acute Respiratory Distress Syndrome Following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse
Masahiro Muto[SUP] 1 2 [/SUP], Yu Sasaki[SUP] 1 2 [/SUP], Toshiki Kano[SUP] 1 2 [/SUP], Yusuke Fukao[SUP] 1 2 [/SUP], Reina Hosoya[SUP] 1 2 [/SUP], Tomohisa Nomura[SUP] 3 [/SUP], Manabu Sugita[SUP] 3 [/SUP], Hiroaki Io[SUP] 1 2 [/SUP], Yusuke Suzuki[SUP] 2 [/SUP]
Affiliations
A 44-year-old man with COVID-19 and nephrotic syndrome relapse was admitted to our intensive-care unit for respiratory failure. Despite receiving mechanical ventilation and immunomodulators, the patient experienced refractory hypoxemia, necessitating venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy. Due to a worsening renal function, continuous hemodiafiltration was initiated. After 11 days, his respiratory status gradually improved, and VV-ECMO was withdrawn. The kidney function and proteinuria improved, and hemodialysis was subsequently discontinued. The patient was discharged 64 days after admission. This case highlights the potential benefit of early ECMO application in dramatically promoting recovery in severe COVID-19 cases.
Keywords: chronic kidney disease; coronavirus disease 2019; extracorporeal membrane oxygenation; nephrotic syndrome relapse.
. 2023 Aug 9.
doi: 10.2169/internalmedicine.2293-23. Online ahead of print. Successful Management of Critical Acute Respiratory Distress Syndrome Following COVID-19 through Extracorporeal Membrane Oxygenation in a Patient with Concurrent Nephrotic Syndrome Relapse
Masahiro Muto[SUP] 1 2 [/SUP], Yu Sasaki[SUP] 1 2 [/SUP], Toshiki Kano[SUP] 1 2 [/SUP], Yusuke Fukao[SUP] 1 2 [/SUP], Reina Hosoya[SUP] 1 2 [/SUP], Tomohisa Nomura[SUP] 3 [/SUP], Manabu Sugita[SUP] 3 [/SUP], Hiroaki Io[SUP] 1 2 [/SUP], Yusuke Suzuki[SUP] 2 [/SUP]
Affiliations
- PMID: 37558472
- DOI: 10.2169/internalmedicine.2293-23
A 44-year-old man with COVID-19 and nephrotic syndrome relapse was admitted to our intensive-care unit for respiratory failure. Despite receiving mechanical ventilation and immunomodulators, the patient experienced refractory hypoxemia, necessitating venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy. Due to a worsening renal function, continuous hemodiafiltration was initiated. After 11 days, his respiratory status gradually improved, and VV-ECMO was withdrawn. The kidney function and proteinuria improved, and hemodialysis was subsequently discontinued. The patient was discharged 64 days after admission. This case highlights the potential benefit of early ECMO application in dramatically promoting recovery in severe COVID-19 cases.
Keywords: chronic kidney disease; coronavirus disease 2019; extracorporeal membrane oxygenation; nephrotic syndrome relapse.